Etanercept treatment in corticosteroid-dependent myasthenia gravis

J. Rowin; M. N. Meriggioli; E. Tüzün; S. Leurgans; P. Christadoss

doi:10.1212/01.WNL.0000147242.92691.71

Etanercept treatment in corticosteroid-dependent myasthenia gravis

J. Rowin, M. N. Meriggioli, E. Tüzün, S. Leurgans, P. Christadoss

Microbiology And Immunology

Research output: Contribution to journal › Article › peer-review

78 Scopus citations

Abstract

The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.

Original language	English (US)
Pages (from-to)	2390-2392
Number of pages	3
Journal	Neurology
Volume	63
Issue number	12
DOIs	https://doi.org/10.1212/01.WNL.0000147242.92691.71
State	Published - Dec 28 2004

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/01.WNL.0000147242.92691.71

Cite this

@article{e43a7c5c8e5b4876af253d5a9dbf18c4,

title = "Etanercept treatment in corticosteroid-dependent myasthenia gravis",

abstract = "The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.",

author = "J. Rowin and Meriggioli, {M. N.} and E. T{\"u}z{\"u}n and S. Leurgans and P. Christadoss",

year = "2004",

month = dec,

day = "28",

doi = "10.1212/01.WNL.0000147242.92691.71",

language = "English (US)",

volume = "63",

pages = "2390--2392",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Etanercept treatment in corticosteroid-dependent myasthenia gravis

AU - Rowin, J.

AU - Meriggioli, M. N.

AU - Tüzün, E.

AU - Leurgans, S.

AU - Christadoss, P.

PY - 2004/12/28

Y1 - 2004/12/28

N2 - The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.

AB - The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.

UR - http://www.scopus.com/inward/record.url?scp=11144331435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144331435&partnerID=8YFLogxK

U2 - 10.1212/01.WNL.0000147242.92691.71

DO - 10.1212/01.WNL.0000147242.92691.71

M3 - Article

C2 - 15623708

AN - SCOPUS:11144331435

SN - 0028-3878

VL - 63

SP - 2390

EP - 2392

JO - Neurology

JF - Neurology

IS - 12

ER -

Etanercept treatment in corticosteroid-dependent myasthenia gravis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this